Condition: Central Visual Impairment · Macular Degeneration · Sponsor: University of Alabama at Birmingham
A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.
This description comes directly from the study's public registry record.
Rachel A Chua, MS · 205-410-4041 · r2chel@uab.edu
Kristina M Visscher, PhD · 205-934-0497 · kmv@uab.edu
Always discuss trial participation with your own doctor first.
| UAB | Birmingham, Alabama, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05454124